Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare Announces Launch and Location of New Scientific Precision Pharmacotherapy Research & Development Institute
MOORESTOWN, N.J. and ORLANDO, Fla.,
Jacques Turgeon, BPharm, PhD, TRHC’s Chief Scientific Officer, has been named CEO of the
According to TRHC Chairman and CEO, Calvin H. Knowlton, PhD, “The TRHC Institute will focus on continuing to enhance our clinical decision support tools through research, using pharmacokinetics and pharmacodynamics modeling, computer simulations, and computational modeling. The overall objective is to optimize and develop new products associated with TRHC’s innovative Medication Risk MitigationTM and Medication Risk StratificationTM technologies. We are pleased to be a part of the innovation that is occurring in Lake Nona Medical City and to have the leadership of Drs. Turgeon and Michaud.”
The TRHC Institute’s research vision expands with the emerging research initiatives that include bioinformatics, biomedical engineering systems, nanoscale science, patient-specific information, data-driven technologies and solutions, and translational research.
The formal announcement of TRHC’s Institute was made today by Drs. Knowlton and Turgeon during the 2019
Dr. Turgeon is internationally recognized for his excellence in research and pharmacy education. He has received more than
Dr. Michaud’s unique expertise in pharmacokinetics, drug-metabolism, drug-drug interactions, pharmacogenomics, and the study of intracellular drug-metabolism will help expand the products developed by the
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
T: (415) 547-7099
Bob East or Asher Dewhurst
T: (443) 213-0500
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7b7a34f8-3132-4aee-a58c-5474c8c2250c
Source: Tabula Rasa HealthCare, Inc.